Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...
Among adults with obesity who lost weight after following a low-calorie diet, weight-loss maintenance with exercise was ...
Translational results bolster confidence as Phase III trial for IMNN-001 in advance epithelial ovarian cancer gets underway.
NEWARK, CALIFORNIA / ACCESS Newswire / September 15, 2025 / Protagonist Therapeutics, Inc. (“Protagonist” or the “Company”) ...
GSK plc (NYSE:GSK) plc Bank of America Global Healthcare Conference 2025 September 24, 2025 4:00 AM EDTCompany ParticipantsJulie Brown - CFO & ...
India - Grant Romiplostim Lyophilized Formulations Patent With Amendments: Madras High Court Directs. Legal News and Analysis ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have rapidly emerged as highly effective pharmacological tools for ...
Bernstein 2nd Annual Global Healthcare Conference September 24, 2025 1:10 PM EDTCompany ParticipantsTom Cavanaugh - ...
In view of persistent fever and cough, and the new onset of an accentuated confluent maculopapular rash, the patient was ...
AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application for Enhertu plus pertuzumab has been accepted for Priority Review b ...